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A dynamic light scattering system combined with a conventional chromatography for sample preparation Institute for Protein Research, Osaka University, E-mail furubayashi@maruwafoods.jp Recent progress in structure determination of proteins by x-ray crystallography allows us to understand the important and complicated mechanism of biological reaction in vivo. However, crystallization process of protein molecules is still the rate determining step caused by difficulty and uncertainty of the sample preparation. Measurement of dynamic light scattering (DLS) is well known as an effective method for evaluation of the sample quality, because DLS results show good correlation between dispersity of the protein solution and possibility of crystallization in many cases. However, it takes a couple of minutes for each samples to measure the polydispersity of molecules, and also, the measurements must be performed in batch mode. If a real-time DLS system is equipped to a conventional chromatography system as a detector for polydispersity of each peak, it is quite useful for evaluation of sample quality. It can be possible to recognize which fraction should be used for crystallization. Therefore, we developed a flow-type cell for a realtime DLS system which can be used as an on-line detector system for a conventional chromatography during the preparation and purification of protein samples. In this study, we report the results of the DLS measurement of alpha amylase from Aspergillus oryzae and other proteins by using FPLC system equipped with the real-time DLS system with the flow-type cell.
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